Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherBasic Science Investigations

Radiopharmaceutical Chemistry of Targeted Radiotherapeutics, Part 2: Radiolytic Effects of 211At α-Particles Influence N-Succinimidyl 3-211At-Astatobenzoate Synthesis

Oscar R. Pozzi and Michael R. Zalutsky
Journal of Nuclear Medicine August 2005, 46 (8) 1393-1400;
Oscar R. Pozzi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael R. Zalutsky
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Normal-phase HPLC profile of radioactive species present after exposure of BuSTB precursor to 211At at doses of 644, 1,658, and 4,157 Gy and acetic acid in chloroform. Arrow indicates retention time of SIB standard. Chromatograms are offset on both axes for display purposes.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Reverse-phase HPLC profile of radioactive species present after exposure of MeSTB precursor to 211At at doses of 1,254, 3,252, and 6,724 Gy and acetic acid in chloroform. Arrows indicate retention times of SIB and IBA standards. Chromatograms are offset on both axes for display purposes.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Production of SAB after incubation of BuSTB and MeSTB with chloroform, acetic acid, and 211At as function of radiation dose.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Effect of sample evaporation on HPLC profile. Shown are chromatograms from reverse-phase HPLC analyses of radioactive species in samples from reaction of MeSTB with methanol, acetic acid, and 211At for reaction mixtures receiving doses of 1,873 Gy (evaporated) and 1,540 Gy (nonevaporated). Arrow indicates SAB.

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    Production of SAB after incubation of BuSTB and MeSTB with methanol, acetic acid, and 211At as function of radiation dose. Error bars indicate SDs.

  • FIGURE 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6.

    Production of SAB from reaction of BuSTB and 211At with methanol and acetic acid by radiolysis (no oxidant added) and radiosynthesis (oxidant added). Decomposition of BuSTB as function of radiation dose (1) is shown for comparison.

  • FIGURE 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 7.

    Effect of addition of acetic acid on SAB synthesis from BuSTB in methanol as function of radiation dose. Error bars indicate SDs.

  • FIGURE 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 8.

    Reverse-phase HPLC profile of radioactive species present after exposure of MeSTB precursor to 211At at doses of 1,900 and 5,316 Gy in benzene and acetic acid. Arrows indicate retention times of MeSTB, SIB, and IBA standards.

  • FIGURE 9.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 9.

    Calculated micromoles of hydrogen and formaldehyde produced in methanol by radiolysis during 20-min reaction period as function of radiation dose. For comparison, broken line shows micromoles of oxidant (NCS) added to SAB radiosynthesis reaction.

Tables

  • Figures
    • View popup
    TABLE 1

    Percentages of Activity Eluted at 18–23 Minutes in Benzene

    PrecursorDose (Gy)% Activity
    MeSTB1,90095
    5,12591
    5,31691
    12,46489
    BuSTB6,98882
    14,58297
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 46 (8)
Journal of Nuclear Medicine
Vol. 46, Issue 8
August 1, 2005
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Radiopharmaceutical Chemistry of Targeted Radiotherapeutics, Part 2: Radiolytic Effects of 211At α-Particles Influence N-Succinimidyl 3-211At-Astatobenzoate Synthesis
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Radiopharmaceutical Chemistry of Targeted Radiotherapeutics, Part 2: Radiolytic Effects of 211At α-Particles Influence N-Succinimidyl 3-211At-Astatobenzoate Synthesis
Oscar R. Pozzi, Michael R. Zalutsky
Journal of Nuclear Medicine Aug 2005, 46 (8) 1393-1400;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Radiopharmaceutical Chemistry of Targeted Radiotherapeutics, Part 2: Radiolytic Effects of 211At α-Particles Influence N-Succinimidyl 3-211At-Astatobenzoate Synthesis
Oscar R. Pozzi, Michael R. Zalutsky
Journal of Nuclear Medicine Aug 2005, 46 (8) 1393-1400;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • THIS MONTH IN JNM
  • PubMed
  • Google Scholar

Cited By...

  • Direct Procedure for the Production of 211At-Labeled Antibodies with an {varepsilon}-Lysyl-3-(Trimethylstannyl)Benzamide Immunoconjugate
  • Clinical Experience with {alpha}-Particle Emitting 211At: Treatment of Recurrent Brain Tumor Patients with 211At-Labeled Chimeric Antitenascin Monoclonal Antibody 81C6
  • Radiopharmaceutical Chemistry of Targeted Radiotherapeutics, Part 3: {alpha}-Particle-Induced Radiolytic Effects on the Chemical Behavior of 211At
  • Targeted {alpha}-Particle Therapy of Microscopic Disease: Providing a Further Rationale for Clinical Investigation
  • Radiation-Induced Biologic Bystander Effect Elicited In Vitro by Targeted Radiopharmaceuticals Labeled with {alpha}-, {beta}-, and Auger Electron-Emitting Radionuclides
  • Potential and Pitfalls of Therapy with {alpha}-Particles
  • Google Scholar

More in this TOC Section

  • PET/MRI of Hypoxic Atherosclerosis Using 64Cu-ATSM in a Rabbit Model
  • Tumor Uptake of Anti-CD20 Fabs Depends on Tumor Perfusion
  • How Sensitive Is the Upper Gastrointestinal Tract to 90Y Radioembolization? A Histologic and Dosimetric Analysis in a Porcine Model
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire